Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SXCP
1851
DELISTED
SunCoke Energy Partners, L.P.
SXCP
| $2.15M | ﹤0.01% |
194,700
+119,700
| +160% | +$1.7M |
|
1852
iShares Russell Mid-Cap ETF
IWR
$57.6B
| $2.15M | ﹤0.01% |
+55,264
| New | +$2.29M |
|
|
BAS
1853
DELISTED
Basis Energy Services, Inc.
BAS
| $2.14M | ﹤0.01% |
1,139
-4,241
| -79% | -$12.9M |
|
|
UNVR
1854
DELISTED
Univar Solutions Inc.
UNVR
| $2.14M | ﹤0.01% |
117,879
-453,754
| -79% | -$10.4M |
|
1855
Stride
LRN
$3.54B
| $2.14M | ﹤0.01% |
171,973
-60,724
| -26% | -$814K |
|
1856
Dr. Reddy's Laboratories
RDY
$10.2B
| $2.13M | ﹤0.01% |
166,335
-42,815
| -20% | -$532K |
|
|
FNFV
1857
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $2.13M | ﹤0.01% |
181,369
-554,323
| -75% | -$8.05M |
|
|
CVRS
1858
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $2.13M | ﹤0.01% |
687,759
+162,226
| +31% | +$586K |
|
1859
HealthStream
HSTM
$841M
| $2.12M | ﹤0.01% |
97,387
+54,644
| +128% | +$1.45M |
|
|
BEE
1860
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $2.12M | ﹤0.01% |
153,863
-54,639
| -26% | -$741K |
|
|
LBRDA
1861
DELISTED
Liberty Broadband Class A
LBRDA
| $2.11M | ﹤0.01% |
41,038
+3,927
| +11% | +$212K |
|
1862
First American
FAF
$7.46B
| $2.11M | ﹤0.01% |
53,910
-47,349
| -47% | -$1.87M |
|
1863
Penske Automotive Group
PAG
$14.4B
| $2.1M | ﹤0.01% |
+43,398
| New | +$2.22M |
|
1864
Geron
GERN
$977M
| $2.1M | ﹤0.01% |
761,072
+390,648
| +105% | +$1.42M |
|
|
TRIL
1865
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.1M | ﹤0.01% |
161,113
+22,660
| +16% | +$416K |
|
1866
Evolent Health
EVH
$555M
| $2.1M | ﹤0.01% |
131,276
-42,895
| -25% | -$837K |
|
1867
Kinross Gold
KGC
$38.3B
| $2.09M | ﹤0.01% |
1,216,090
-3,003,648
| -71% | -$5.49M |
|
1868
United Rentals
URI
$65.8B
| $2.09M | ﹤0.01% |
34,837
-253,631
| -88% | -$17.6M |
|
1869
Murphy Oil
MUR
$4.98B
| $2.09M | ﹤0.01% |
86,299
+46,299
| +116% | +$1.48M |
|
1870
New York Times
NYT
$11.1B
| $2.09M | ﹤0.01% |
+176,808
| New | +$2.23M |
|
1871
Caleres
CAL
$449M
| $2.08M | ﹤0.01% |
68,286
-164,482
| -71% | -$5.3M |
|
1872
PUT
LyondellBasell Industries
LYB
$20.1B
| $2.08M | ﹤0.01% |
+25,000
| New | +$2.22M |
|
1873
CALL
Chord Energy
CHRD
$7.74B
| $2.08M | ﹤0.01% |
+240,000
| New | +$2.51M |
|
|
EPRS
1874
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $2.08M | ﹤0.01% |
471,240
+378,951
| +411% | +$2.23M |
|
|
ASRT
1875
DELISTED
Assertio
ASRT
| $2.08M | ﹤0.01% |
+1,841
| New | +$3.14M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.